Complete pathologic response rate to neoadjuvant chemotherapy increases with increasing HER2/CEP17 ratio in HER2 overexpressing breast cancer: analysis of the National Cancer Database (NCDB)

Kathriena Greenwell, Lala R. Hussain, David Lee, Matthew Bramlage, Gordon Bills, Apurva Mehta, Amie E. Jackson, Barbara Wexelman